NCT05485805View on ClinicalTrials.gov

A Study to Learn How Well a Single Dose of the Study Treatment Naproxen Sodium and Caffeine Combined in One Tablet (Fixed-dose Combination) Works to Relieve Pain After Dental Surgeries Compared to the Single Ingredients and to Placebo

PHASE3CompletedINTERVENTIONAL
Enrollment

541

Participants

Timeline

Start Date

September 21, 2022

Primary Completion Date

January 25, 2024

Study Completion Date

January 29, 2024

Conditions
Postoperative Dental Pain
Interventions
DRUG

Naproxen sodium and caffeine (BAY2880376)

Tablet, oral use, single dose

DRUG

Naproxen sodium (Aleve)

Tablet, oral use, single dose

DRUG

Caffeine

Tablet, oral use, single dose

DRUG

Placebo

Tablet, oral use, single dose

Trial Locations (1)

84107

JBR Clinical Research, Salt Lake City

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT05485805 - A Study to Learn How Well a Single Dose of the Study Treatment Naproxen Sodium and Caffeine Combined in One Tablet (Fixed-dose Combination) Works to Relieve Pain After Dental Surgeries Compared to the Single Ingredients and to Placebo | Biotech Hunter | Biotech Hunter